GDOCvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with GDOC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/17/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GDOC ETF 2 | -0.05%– | +11.63%– | +4.53%– | +15.38%– | +20.08%– | n/a– |
| Flows | GDOC ETF 2 | -– | -$3M– | -$2M– | -$3M– | -$86M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GDOC ETF 2 | +15.48%– | +15.28%– | +14.98%– | n/a– |
| Max drawdown | GDOC ETF 2 | -6.08%– | -15.39%– | -22.18%– | n/a– |
| Max drawdown duration | GDOC ETF 2 | 29d– | 221d– | 449d– | n/a– |
Trading data
GDOC | ETF 2 | |
Last sale 9/17/2026 at 1:30 PM | $37.25 | – |
| Previous close 09/17/2026 | $36.84 | – |
| Consolidated volume 09/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/17/2026 at 1:30 PM
Live
Closed
GDOC | ETF 2 | |
|---|---|---|
| Last price | $37.25 | – |
| 1D performance | +1.12% | – |
| AuM | $19.55 M | – |
| E/R | 0.75% | – |
Characteristics
GDOC | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Goldman Sachs | – |
| Benchmark | - | – |
| N° of holdings | 38 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 11, 2021 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
GDOC
USA
79.52%
Other
20.48%
ETF 2
Sectors
GDOC
Healthcare
97.92%
Other
2.08%
ETF 2
Diversification
GDOC
Total weight of top 15 holdings out of 15
71.18%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
GDOC
Eli Lilly & Co.
13.11%
Johnson & Johnson
8.63%
Merck & Co., Inc.
6.83%
UnitedHealth Group, Inc.
6.44%
Guardant Health, Inc.
4.41%
argenx SE
3.71%
AstraZeneca PLC
3.59%
Edwards Lifesciences Corp.
3.30%
Thermo Fisher Scientific, Inc.
3.30%
Agilent Technologies, Inc.
3.28%
DexCom, Inc.
3.23%
Apogee Therapeutics, Inc.
3.00%
Intuitive Surgical, Inc.
2.88%
Lonza Group AG
2.79%
Cencora, Inc.
2.67%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
